Substructure in clusters containing wide-angle tailed radio galaxies. I. New redshifts

We present new redshifts and positions for 635 galaxies in nine rich clusters containing Wide-Angle Tailed (WAT) radio galaxies. Combined with existing data, we now have a sample of 18 WAT-containing clusters with more than 10 redshifts. This sample contains a substantial portion of the WAT clusters in the VLA 20 cm survey of Abell clusters, including 75% of WAT clusters in the complete survey (z0.09. It is a representative sample which should not contain biases other than selection by radio morphology. We graphically present the new data using histograms and sky maps. A semi-automated procedure is used to search for emission lines in the spectra in order to add and verify galaxy redshifts. We find that the average apparent fraction of emission line galaxies is about 9% in both the clusters and the field. We investigate the magnitude completeness of our redshift surveys with CCD data for a test case, Abell 690. This case indicates that our galaxy target lists are deeper than the detection limit of a typical MX exposure, and they are 82% complete down to R=19.0. The importance of the uniformity of the placement of fibers on targets is posited, and we evaluate this in our datasets. We find some cases of non-uniformities which may influence dynamical analyses. A second paper will use this database to look for correlations between the WAT radio morphology and the cluster's dynamical state.Comment: 15 pages, 5 figures, 7 tables. To appear in the Astronomical Journa

An Optimal Control Approach to Sensor / Actuator Placement for Optimal Control of High Performance Buildings

In this paper we consider the problem of best sensor location for optimal state estimation for real time energy efficient optimal control. Although the basic idea can be applied to the joint sensor / actuator location problem, we focus on the sensor placement because of its immediate application to retrofits where sensors can easily relocated while the location of control inputs (diffusers, vents, etc.) are less movable. It is important to note that this approach does not require “time accurate high fidelity simulations” and has been successful in other disciplines such as structural control, control of chemical processes and fluid flow control. We show how these techniques can be applied to high performance building design and control. We present the theoretical basis for the method, discuss the computational requirements and use simple models to illustrate the ideas and numerical methods for solution. We then apply the method results to a multi-zone hospital suite problem

Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conduct

Background In 2010, after regulatory review of rosiglitazone licensing, the US Food and Drug Administration (FDA) requested a reevaluation of cardiovascular end points in the RECORD trial.<p></p> Methods Automated screening of the original clinical trial database and manual case report form review were performed to identify all potential cardiovascular and noncardiovascular deaths, and nonfatal myocardial infarction (MI) and stroke events. Search techniques were used to find participants lost to follow-up, and sites were queried for additional source documents. Suspected events underwent blinded adjudication using both original RECORD end point definitions and new FDA end point definitions, before analysis by the Duke Clinical Research Institute.<p></p> Results The reevaluation effort included an additional 328 person-years of follow-up. Automated screening identified 396 suspected deaths, 2,052 suspected MIs, and 468 suspected strokes. Manual review of documents by Duke Clinical Research Institute clinical events classification (CEC) coordinators identified an additional 31 suspected deaths, 49 suspected MIs, and 28 suspected strokes. There were 127 CEC queries issued requesting additional information on suspected deaths; 43 were closed with no site response, 61 were closed with a response that no additional data were available, and additional data were received for 23. Seventy CEC queries were issued requesting additional information for suspected MI and stroke events; 31 were closed with no site response, 20 were closed with a response that no additional data were available, and 19 resulted in additional data.<p></p> Conclusions Comprehensive procedures were used for rigorous event reascertainment and readjudication in a previously completed open-label, global clinical trial. These procedures used in this unique situation were consistent with other common approaches in the field, were enhanced to address the FDA concerns about the original RECORD trial results, and could be considered by clinical trialists designing event readjudication protocols for drug development programs that have been completed.<p></p&gt

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

Background The US Food and Drug Administration (FDA) required a reevaluation of cardiovascular (CV) outcomes in the RECORD trial. This provided an opportunity to assess the implications of event adjudication by 2 groups and quantify the differences as well as to use new FDA end point definitions in development.<p></p> Methods Original data were used to systematically identify all potential deaths, myocardial infarctions (MIs), and strokes. Site investigators were approached for additional source documents and information about participants lost to follow-up. Suspected events were adjudicated using standard procedures, and the results were compared with the original trial outcomes.<p></p> Results Follow-up for mortality was 25,833 person-years, including an additional 328 person-years identified during the reevaluation effort. A total of 184 CV or unknown-cause deaths (88 rosiglitazone, 96 metformin/sulfonylurea), 128 participants with an MI (68 rosiglitazone, 60 metformin/sulfonylurea), and 113 participants with a stroke (50 rosiglitazone, 63 metformin/sulfonylurea) were included. The hazard ratio (HR) for rosiglitazone versus metformin/sulfonylurea for the end point of CV (or unknown cause) death, MI, or stroke was 0.95 (95% CI 0.78-1.17) compared with 0.93 (95% CI 0.74-1.15) for the original RECORD results. Treatment comparisons for MI (HR 1.13, 95% CI 0.80-1.59) and mortality (HR 0.86, 95% CI 0.68-1.08) were also the same compared with the original RECORD results. Sensitivity analyses were also consistent with the original RECORD results. Analyses using the FDA definitions showed similar results.<p></p> Conclusions Only a modest number of additional person-years of follow-up were ascertained from this reevaluation of CV end points in RECORD. Observed HRs and CIs from these analyses using the original RECORD or new FDA end point definitions showed similar treatment effects of rosiglitazone compared with the original RECORD results.<p></p&gt

Blastomyces Antigen Detection for Monitoring Progression of Blastomycosis in a Pregnant Adolescent

Although disseminated blastomycosis is a rare complication in pregnancy, delay in diagnosis and treatment can be fatal. We investigate the use of the Blastomyces urine antigen in diagnosis following disease progression in the intrapartum, postpartum, and neonatal periods. We describe a case of disseminated blastomycosis in a pregnant adolescent and review the pertinent literature regarding treatment and monitoring blastomycosis in pregnancy and the neonatal periods. This is the first reported case in which the Blastomyces urine antigen is utilized as a method of following disease activity during pregnancy confirming absence of clinically evident disease in a neonate. Urine antigen detection for blastomycosis can be useful for following progression of disease in patients with disseminated blastomycosis in both the intrapartum and postpartum periods

Influence of asymptomatic pneumonia on the response to hemorrhage and resuscitation in swine

INTRODUCTION: Investigation of resuscitation fluids in our swine hemorrhage model revealed moderate to severe chronic pneumonia in five swine at necropsy. Our veterinary staff suggested that we perform a retrospective analysis of prospectively collected data from these animals. We compared the data to that of ten healthy swine to determine the physiologic consequences of the added stress on our hemorrhage/resuscitation model. METHODS: Anesthetized, immature female swine (40 ± 5 kg) were instrumented for determining arterial and venous pressures, cardiac output and urine production. A controlled hemorrhage of 20 ml/kg over 4 min 40 sec was followed at 30 min by a second hemorrhage of 8 ml/kg and resuscitation with 1.5 ml/kg/min of LR solutions to achieve and maintain systolic blood pressure at 80 ± 5 mmHg for 3.5 hrs. Chemistries and arterial and venous blood gasses were determined from periodic blood samples along with hemodynamic variables. RESULTS: There were significant decreases in survival, urine output, cardiac output and oxygen delivery at 60 min and O2 consumption at 120 min in the pneumonia group compared to the non-pneumonia group. There were no differences in other metabolic or hemodynamic data between the groups. CONCLUSION: Although pneumonia had little influence on pulmonary gas exchange, it influenced cardiac output, urine output and survival compared to healthy swine, suggesting a decrease in the physiologic reserve. These data may be relevant to patients with subclinical infection who are stressed by hemorrhage and may explain in part why some similarly injured patients require more resuscitation efforts than others

Do glucose containing beverages play a role in thermoregulation, sensation, and mood state?

Introduction Dehydration limits the appropriate delivery of oxygen and substrates to the working muscle. Further, the brain’s ability to function may also be compromised whereby thermal sensation and mood state may be altered. Purpose The purpose of the present investigation was to compare the thermoregulatory, perceptual, and negative mood state profile in glucose (GLU) vs. non-glucose beverage (NON-GLU) condition. Methods Ten healthy men volunteered and were counterbalanced either a GLU or NON-GLU containing beverage on separate mornings. In each condition, they were exposed to 37°C, 50% relative humidity (RH) for baseline, exercise, rehydration, and recovery periods. The exercise period elicited the desired level of dehydration (mean of 2.6 ± 0.3% body weight losses). Upon completion of the protracted exercise, participants were administered either a GLU or NON-GLU containing electrolyte based sports drink ad libitum for 30 min, followed by a recovery period of 15 min in 37°C, 50% RH. Rectal (Tre) and mean skin temperatures (Tsk) were continuously monitored. Gagge (TS) and heated thermal sensation (HTS), profile of mood state (POMS) were measure at the end of each period. Results During recovery after rehydration, Tre was not significantly different between conditions (GLU vs. NON-GLU) (37.4 ± 0.8 vs. 37.0 ± 1.2°C); Tsk was also not affected by rehydration in both conditions (36.0 ± 0.5 vs. 36.0 ± 0.6°C) and, TS and HTS did not differ between conditions (0.9 ± 1.3 vs.1.3 ± 0.7) and (1.0 ± 0.8 vs.0.8 ± 0.3). Total mood disturbance (TMD) score for the POMS was utilized for overall negative mood state and demonstrated a main effect for time (p \u3c 0.05). TMD during recovery was decreased compared to before hydration in both conditions. Conclusion The non-glucose containing beverage maintained plasma volume and was effective at maintaining body temperature homeostasis in a similar fashion compared to the glucose containing beverage. Furthermore, negative mood state was not different between the two conditions. The non-glucose beverages can serve a valuable role in the exercise environment depending upon the sport, the ambient temperature, the individual, duration of the exercise, the age and training states of the individual

Do glucose containing beverages play a role in thermoregulation, thermal sensation, and mood state?

INTRODUCTION: Dehydration limits the appropriate delivery of oxygen and substrates to the working muscle. Further, the brain’s ability to function may also be compromised whereby thermal sensation and mood state may be altered. PURPOSE: The purpose of the present investigation was to compare the thermoregulatory, perceptual, and negative mood state profile in glucose (GLU) vs. non-glucose beverage (NON-GLU) condition. METHODS: Ten healthy men volunteered and were counterbalanced either a GLU or NON-GLU containing beverage on separate mornings. In each condition, they were exposed to 37°C, 50% relative humidity (RH) for baseline, exercise, rehydration, and recovery periods. The exercise period elicited the desired level of dehydration (mean of 2.6 ± 0.3% body weight losses). Upon completion of the protracted exercise, participants were administered either a GLU or NON-GLU containing electrolyte based sports drink ad libitum for 30 min, followed by a recovery period of 15 min in 37°C, 50% RH. Rectal (Tre) and mean skin temperatures (Tsk) were continuously monitored. Gagge (TS) and heated thermal sensation (HTS), profile of mood state (POMS) were measure at the end of each period. RESULTS: During recovery after rehydration, Tre was not significantly different between conditions (GLU vs. NON-GLU) (37.4 ± 0.8 vs. 37.0 ± 1.2°C); Tsk was also not affected by rehydration in both conditions (36.0 ± 0.5 vs. 36.0 ± 0.6°C) and, TS and HTS did not differ between conditions (0.9 ± 1.3 vs.1.3 ± 0.7) and (1.0 ± 0.8 vs.0.8 ± 0.3). Total mood disturbance (TMD) score for the POMS was utilized for overall negative mood state and demonstrated a main effect for time (p < 0.05). TMD during recovery was decreased compared to before hydration in both conditions. CONCLUSION: The non-glucose containing beverage maintained plasma volume and was effective at maintaining body temperature homeostasis in a similar fashion compared to the glucose containing beverage. Furthermore, negative mood state was not different between the two conditions. The non-glucose beverages can serve a valuable role in the exercise environment depending upon the sport, the ambient temperature, the individual, duration of the exercise, the age and training states of the individual